Literature DB >> 22516062

Osteoprotegerin is associated with aneurysm diameter and proteolysis in abdominal aortic aneurysm disease.

Dave Koole1, Rob Hurks, Arjan Schoneveld, Aryan Vink, Jonathan Golledge, Corey S Moran, Dominique P de Kleijn, Joost A van Herwaarden, Jean-Paul de Vries, Jon D Laman, Ruth Huizinga, Gerard Pasterkamp, Frans L Moll.   

Abstract

OBJECTIVE: Serum osteoprotegerin (OPG) concentrations have previously been associated with growth of abdominal aortic aneurysms (AAAs). In vitro experiments showed that OPG promotes matrix metalloprotease (MMP) release from monocytes and vascular smooth muscle cells. We hypothesized that OPG expression is increased in human AAAs and is associated with proteolysis. METHODS AND
RESULTS: AAA biopsies were collected from 329 patients. We assessed the concentrations of OPG, cathepsins A, B, and S as well as the activity of MMP-2 and MMP-9. The AAA wall infiltration by macrophages, lymphocytes, and plasma cells was estimated by immunohistochemistry. The concentration of OPG correlated positively with aortic diameter (<55 mm: 16.1 [5.8-28.7], 55-70 mm: 21.9 [10.2-36.0], >70 mm: 24.0 [13.5-52.9] ng OPG/mg total amount of protein, P=0.020), cathepsin A (r=0.221, P=0.005), B (r=0.384, P<0.001), and S (r=0.467, P<0.001), MMP-2 (r=0.180, P<0.001), MMP-9 (r=0.178, P<0.001), and the number of lymphocytes (P<0.001) and plasma cells (P=0.001). OPG immunostaining was predominantly demonstrated in plasma cells.
CONCLUSIONS: The concentration of aortic wall OPG is positively associated with established markers of AAA severity and pathogenesis. OPG appeared to be associated with lymphocytes and plasma cells. These human data support previous experimental data suggesting a role for OPG in AAA pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22516062     DOI: 10.1161/ATVBAHA.111.243592

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  12 in total

1.  Plasma levels of cathepsins L, K, and V and risks of abdominal aortic aneurysms: a randomized population-based study.

Authors:  Bing-Jie Lv; Jes S Lindholt; Jing Wang; Xiang Cheng; Guo-Ping Shi
Journal:  Atherosclerosis       Date:  2013-07-14       Impact factor: 5.162

2.  Large cavernous carotid artery aneurysm with spontaneous thrombosis: is there more to a change in morphology than there seems to be? Illustrative case.

Authors:  Yoriko Kato; Wataro Tsuruta; Hisayuki Hosoo; Tetsuya Yamamoto
Journal:  J Neurosurg Case Lessons       Date:  2021-08-16

Review 3.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

4.  Osteoprotegerin deficiency limits angiotensin II-induced aortic dilatation and rupture in the apolipoprotein E-knockout mouse.

Authors:  Corey S Moran; Roby J Jose; Erik Biros; Jonathan Golledge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-09       Impact factor: 8.311

Review 5.  Micromanaging abdominal aortic aneurysms.

Authors:  Lars Maegdefessel; Joshua M Spin; Matti Adam; Uwe Raaz; Ryuji Toh; Futoshi Nakagami; Philip S Tsao
Journal:  Int J Mol Sci       Date:  2013-07-11       Impact factor: 5.923

6.  Osteoprotegerin Prevents Development of Abdominal Aortic Aneurysms.

Authors:  Batmunkh Bumdelger; Hiroki Kokubo; Ryo Kamata; Masayuki Fujii; Koichi Yoshimura; Hiroki Aoki; Yuichi Orita; Takafumi Ishida; Megu Ohtaki; Masataka Nagao; Mari Ishida; Masao Yoshizumi
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

7.  Parenteral administration of factor Xa/IIa inhibitors limits experimental aortic aneurysm and atherosclerosis.

Authors:  Corey S Moran; Sai-Wang Seto; Smriti M Krishna; Surabhi Sharma; Roby J Jose; Erik Biros; Yutang Wang; Susan K Morton; Jonathan Golledge
Journal:  Sci Rep       Date:  2017-02-21       Impact factor: 4.379

8.  Disruption of Osteoprotegerin has complex effects on medial destruction and adventitial fibrosis during mouse abdominal aortic aneurysm formation.

Authors:  Batmunkh Bumdelger; Mikage Otani; Kohei Karasaki; Chiemi Sakai; Mari Ishida; Hiroki Kokubo; Masao Yoshizumi
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

Review 9.  Novel biomarkers of abdominal aortic aneurysm disease: identifying gaps and dispelling misperceptions.

Authors:  Demetrios Moris; Eleftherios Mantonakis; Efthymios Avgerinos; Marinos Makris; Chris Bakoyiannis; Emmanuel Pikoulis; Sotirios Georgopoulos
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

10.  Osteopontin and Osteoprotegerin as Potential Biomarkers in Abdominal Aortic Aneurysm before and after Treatment.

Authors:  Konstantinos Filis; Vasilios Martinakis; George Galyfos; Fragiska Sigala; Dimitris Theodorou; Ioanna Andreadou; Georgios Zografos
Journal:  Int Sch Res Notices       Date:  2014-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.